- ISIL creates all-female brigade to terrorize women into following Sharia law
- ISTOOK: Obama wants to be impeached
- Obama to Latin leaders: Help with border
- Military bans troops from Baptist church event honoring ‘God’s Rescue Squad’
- ‘Pocket drones’: U.S. Army developing tiny surveillance tools for the next big war
- Belgian cafe posts sign: Dogs allowed, but Jews stay out
- Gen. Dempsey: Pentagon studying Russian readiness plans not viewed ‘for 20 years’
- John McCain: Botched, two-hour execution of murderer is ‘torture’
- House GOP ready to move border bill
- Bomb squad called after live WWII artillery washes on Cape Cod beach
Eli Lilly suspends cancer study on safety concerns
Question of the Day
INDIANAPOLIS (AP) - Eli Lilly and co. said Monday that it suspended a late-stage study of tasisulam as a potential skin cancer treatment because of safety concerns, but the company will continue ongoing studies in other types of cancer.
The company did not disclose the specific safety issues involved in the suspension. Researchers are analyzing the data in the study on metastatic melanoma patients. The condition is the deadliest form of skin cancer.
“We are thoroughly reviewing the clinical trial data to understand what modifications to the study protocol or dosing would be needed to improve patient safety on this trial,” said Dr. Richard Gaynor, vice president of oncology product development and medical affairs for Lilly, in a statement.
The study focuses on tasisulam as a secondary treatment for patients whose melanoma has spread. It involves more than 300 patients in 18 countries.
Meanwhile, the company said it will continue to develop the drug as a potential treatment for breast, ovarian and other cancers, citing different dosing. The company said it is closely evaluating patient safety in those trials on an ongoing basis.
Shares of Eli Lilly rose 5 cents to $35.02 in after-hours trading after falling a penny to close at $34.97 during the regular trading session.
TWT Video Picks
By Mark Davis
The nation founders, the Lone Star State thrives
- Rahm Emanuel: Send illegal immigrant shelter kids to Chicago
- Tactical advantage: Russian military shows off impressive new gear
- 'Pocket drones': U.S. Army developing tiny spies for the next big war
- Family of Marine killed in Afghanistan pushes back against cover-up
- CURL: Obama, staffers not even pretending any more
- Pentagon running out of time to find mass of missing weapons in Afghanistan
- Federal judge rules D.C. ban on handguns in public is unconstitutional
- D.C. seeks stay in order striking down ban on handguns in public
- The List: Top 20 TV medical shows
- NAPOLITANO: What if our democracy is a fraud?
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq